Clinical trial · Observational
Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata
Lower UTI Evaluation in Women With Uterine Leiomyomata
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To the investigators knowledge there is no research data published to date regarding the lower urinary tract symptoms in women with leiomyomas. The primary aims of this study are: 1. To determine prevalence of lower urinary tract symptoms in patients who present for care for symptomatic leiomyomata. 2. To compare change in lower urinary tract symptoms within treatment groups measured by the UDI-6 total before and at six months after three common treatments for symptomatic uterine fibroids including: hysterectomy, myomectomy, or uterine artery embolization. The study proposed here will hopefully answer the question if one particular therapy is appropriate to treat fibroids and relieve lower urinary tract symptoms.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leiomyoma | Leiomyoma | ONTOLOGY_EXACT | 0.98 |
| Urinary Tract Infection | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To measure prevalence of lower urinary tract symptoms including urinary incontinence symptoms in patients who present for care for symptomatic leiomyomata.
- timeFrame
- Post treatment change
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who are at least 18 years of age, * Vaginal bleeding secondary to anatomic uterine leiomyomas confirmed at the Cleveland Clinic Fibroid and Menstrual Disorders Center, * Patients complaining of mass effect symptoms due to fibroids, and * Patients undergoing either hysterectomy, myomectomy, or uterine artery embolization Exclusion Criteria: * Patients who are pregnant, or * Diagnosis of solitary or multiple intracavitary fibroids without subserosal or intramural leiomyomas present, or * Prior or interval anti-incontinence procedure, or * Patients with a urinary tract infection, or * Patients taking anti-cholinergic medications, or * Presence of an adnexal mass, or * Unable or unwilling to complete a follow up survey at six months following treatment
References
Publications (0)
Data not yet available